ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 78 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $945,000 | -31.9% | 369,025 | -23.1% | 0.00% | -100.0% |
| Q1 2020 | $1,388,000 | -19.3% | 480,137 | +5.7% | 0.00% | 0.0% |
| Q4 2019 | $1,721,000 | +59.2% | 454,062 | +114.7% | 0.00% | – |
| Q3 2019 | $1,081,000 | +67.6% | 211,479 | +103.3% | 0.00% | – |
| Q2 2019 | $645,000 | – | 104,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,474,482 | $38,661,000 | 18.12% |
| GREAT POINT PARTNERS LLC | 772,600 | $20,258,000 | 7.90% |
| BOW STREET LLC | 126,870 | $3,327,000 | 1.61% |
| Opaleye Management Inc. | 150,000 | $3,933,000 | 1.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 316,690 | $8,304,000 | 0.64% |
| WALL STREET ASSOCIATES | 225,000 | $5,899,000 | 0.56% |
| Granite Point Capital Management, L.P. | 61,813 | $1,621,000 | 0.47% |
| EMERALD ADVISERS, LLC | 348,721 | $9,143,000 | 0.44% |
| TFS CAPITAL LLC | 97,652 | $2,560,000 | 0.25% |
| Spark Investment Management LLC | 59,300 | $1,553,000 | 0.22% |